Maldeployment of Celt ACD vascular closure device

Area of Science:

• Vascular surgery
• Medical device technology
• Patient safety

Background:

• Vascular closure devices (VCDs) are increasingly used for arterial access site closure.
• They offer advantages such as expedited hemostasis and earlier patient ambulation compared to manual compression.
• Despite benefits, VCDs carry risks if not deployed correctly.

Observation:

• Two distinct cases involving the Celt arterial closure device are presented.
• In both instances, the device was maldeployed, indicating a failure in the intended application process.
• The maldeployment directly correlated with adverse patient outcomes.

Findings:

• Maldeployment of the Celt arterial closure device can lead to significant patient morbidity.
• Specific complications arising from maldeployment were observed, underscoring the device-specific risks.
• These cases illustrate potential failure modes in VCD technology.

Implications:

• Clinicians must exercise caution and adhere strictly to deployment protocols for vascular closure devices.
• Further research into VCD design and user training may be warranted to minimize maldeployment risks.
• Patient safety protocols should address potential complications associated with arterial closure device use.